NextCure, Inc. (NXTC)
NASDAQ · Healthcare
NextCure, Inc. Shareholder Equity 2020–2025
NextCure, Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- NextCure, Inc. shareholder equity as of December 31, 2025: 34.9M, a 46.63% decrease year-over-year.
- NextCure, Inc. shareholder equity for 2025 were 34.9M, a 46.63% decrease from 2024.
- NextCure, Inc. shareholder equity for 2024 were 65.5M, a 42.78% decrease from 2023.
- NextCure, Inc. shareholder equity for 2023 were 114.4M, a 31.70% decrease from 2022.
- NextCure, Inc. shareholder equity for 2022 were 167.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| NextCure, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $35 |
| 2024 | $65 |
| 2023 | $114 |
| 2022 | $168 |
| 2021 | $233 |
| 2020 | $294 |
NextCure, Inc. Shareholder Equity — FAQ
NextCure, Inc. (NXTC) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NXTC's shareholder equity history?
The chart and table above show NextCure, Inc.'s shareholder equity by year and by quarter, including the growth rate.